Current location - Education and Training Encyclopedia - Educational institution - What are the CRO companies in China?
What are the CRO companies in China?
CRO refers to R&D pharmaceutical contract outsourcing service organization:

1. The largest CRO company in China is Tiger Medicine, whose main business is clinical trials and registration. 20 12 went public.

Followed by Beijing Yuan Bo CRO, Guangzhou Ji Bo, Shanghai Dong Run Ke Ruohua and so on.

3. Garbo Medical Information Consulting Service (Shanghai) Co., Ltd. ..

Mestar (Shanghai) Pharmaceutical Development Co., Ltd..

5. Ding Jing Pharmaceutical R&D (Shanghai) Co., Ltd. ..

6. Shanghai Xinshengyuan Pharmaceutical Research Co., Ltd. ..

7. Shanghai Jianli Pharmaceutical Technology Co., Ltd. ..

8. Shanghai Cisco Pharmaceutical Technology Co., Ltd. ..

9. Lanling Technology Consulting (Shanghai) Co., Ltd. ..

10, Shanghai watson biological Medical Technology Co., Ltd.

1 1, Shanghai Guang Zhi Business Consulting Co., Ltd.

12, Shanghai Hu Yun Pharmaceutical Development Co., Ltd. (Hu Yun Pharmaceutical).

Extended data:

competitive edge

The first is the integration of outsourcing services. CRO outsourcing services can cover the whole stage of global pharmaceutical research and development. From the research and development of new drugs to the listing of new drugs, large multinational CRO enterprises can provide one-stop comprehensive services. At present, the overall CRO industry in China has just started, and its industrial scale has great development potential.

For CRO local enterprises, how to build a complete industrial service chain in the future can not only improve the technological innovation ability of China's pharmaceutical industry, but also promote China to enter the upstream of the pharmaceutical industry value chain as soon as possible, which is also the inevitable result of meeting the growing demand of China's pharmaceutical market.

Secondly, the internationalization of qualification certification standards. As an important part of the global pharmaceutical industry value chain, CRO is bound to be in line with the global standards system. After the establishment of SFDA(2065 438+03. 22 renamed as CFDA), China vigorously promoted the construction of quality standard systems such as GMP, GCP and GLP, and gradually approached the quality standard systems of western developed countries.

But it is undeniable that compared with the strict quality system of western developed countries, especially the United States, China still has a long way to go. For the real outsourcing business of new drug research and development, how to meet the standards of western countries (such as the GLP standard of FDA) will also be a necessary condition for the future development of CRO local enterprises.

Baidu encyclopedia -CRO(R&D medicine outsourcing service organization)